Effect of Anti-Topoisomerase I Antibody Status on Decline in Lung Function in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease: Data from the SENSCIS Trial - Mayes, Maureen; Highland, Kristin; Gahlemann, Martina; Fischer, Aryeh; Raghu, Ganesh; Girard, Mannaig; Alves, Margarida; Stowasser, Susanne; Distler, Jörg; Matucci-Cerinic, Marco; Volkmann, Elizabeth; Kuwana, Masataka; et al. (ARTHRITIS & RHEUMATOLOGY, 2019)
CRIS-Team WoS Importer:2020-02-07